FORT LAUDERDALE, Fla. Home Diagnostics on Tuesday announced that it was named one of Forbes magazine’s “200 Best Small Companies” in the October 27 issue of that publication, which makes for HDI’s debut on the Forbes list.
“Being recognized by Forbes as one of the nation’s best small companies is a testament to the success of Home Diagnostics’ growth strategy,” stated Richard Damron, Jr., president and chief executive officer of Home Diagnostics. “National pharmacy chains, distributors and mail service providers trust our blood glucose monitoring systems to represent their own brands because we offer high-performance products at a significant cost savings to their diabetic customers. Our ability to capitalize on our unique distribution model and gain market share with competitive price points positions Home Diagnostics as a strong player in a growing $7 billion diabetes testing supplies market.”
“The Forbes list of the 200 Best Small Companies seeks to identify the strongest public companies with sales under $750 million,” said Kurt Badenhausen associate editor at Forbes. “These firms all have reasonable debt burdens and have had solid sales and earnings growth over the past five years.”